Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Tuesday preview: US inflation report in focus amid tariff uncertainty

(Sharecast News) - Economic data is set to steal the show on Tuesday as no major earnings are due from London-listed blue chips, with figures on UK unemployment, German investor confidence and US inflation scheduled for release during the trading session. The US inflation report will be the market-moving event of the day and comes at a time when economists are still attempting to calculate the impact of Donald Trump's fluctuating trade policies on consumer prices.

According to consensus estimates, the CPI index is expected to have risen by 0.3% in April after a 0.1% decline in March, though the year-on-year rate is tipped to have held steady. The key figure for core inflation, meanwhile, is estimated to be unchanged at 2.8%.

"Although headline inflation is expected remain steady, this will still be a litmus test for the inflationary impact of US tariffs," said Kathleen Brooks, research director at XTB, though she stressed that April's prices likely won't truly reflect the impact of tariffs due to lag effects.

"Ironically, prices could surprise on the downside, even with tariff risks, as businesses tried to entice consumers to buy products or go out and spend money, in a tough environment," she said.

Whatever the outcome on Tuesday, investors will likely still be reacting to this weekend's trade talks between China and the US, where the two nations agreed to cut levies for the next 90 days. Washington will reduce tariffs on Chinese goods to 30% from 145%, while Beijing will lower duties to 10% from 125%.

"Tariffs at 30% on Chinese goods are better than tariffs at 145%, but 30% is still a hefty sum, which could hit the consumer and the inflation rate down the line," Brooks said.

In the UK, the focus will be on employment figures for March. Growth in average earnings including bonuses is expected to have slowed from a quarterly annual pace of 5.6% to 5.2%.The rate of unemployment is forecast to have ticked higher by a tenth of a percentage point to 4.5%.

In Germany, the closely followed ZEW survey measuring confidence among analysts and institutional investors is expected to show that the economic sentiment index improved to 13.7 in May from -14 in April.

Tuesday 13 May

INTERIMS

On The Beach Group , Renew Holdings, Treatt

INTERIM DIVIDEND PAYMENT DATE

VinaCapital Vietnam Opportunity Fund Ltd.

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Consumer Price Index (US) (13:30)

Current Account (GER) (13:30)

ZEW Survey (EU) - Economic Sentiment (10:00)

ZEW Survey (GER) - Current Situation (10:00)

ZEW Survey (GER) - Economic Sentiment (10:00)

FINALS

Angling Direct , Bytes Technology Group , Diaceutics , IQE

AGMS

Baronsmead Venture Trust, Fisher (James) & Sons, Henderson High Income Trust, HUTCHMED (China) Limited, ITV, Macfarlane Group, Midwich Group, Phoenix Group Holdings , Serinus Energy NPV, St James's Place

UK ECONOMIC ANNOUNCEMENTS

BRC Sales Monitor (00:01)

Claimant Count Rate (07:00)

Unemployment Rate (07:00)

FINAL DIVIDEND PAYMENT DATE

Abrdn , Fidelity European Trust, Morgan Advanced Materials , OSB Group , Rathbones Group

Q1

Telecom Egypt SAE GDS (Regs)

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.